首页> 外国专利> A drug combination product, comprising a nucleic acid and an immunosuppressive drug, in combination with a cytotoxic agent for the treatment of herpes simplex virus infection

A drug combination product, comprising a nucleic acid and an immunosuppressive drug, in combination with a cytotoxic agent for the treatment of herpes simplex virus infection

机译:一种药物组合产品,其包含核酸和免疫抑制药物以及细胞毒性剂,用于治疗单纯疱疹病毒感染

摘要

Drug components include an active nuclide similar to herpes simplex virus, such as aciclovir / valaciclovir or pencelovir / famciclovir, and an immunosuppressant, as a mixed preparation used at the same time, which is sequentially isolated in the treatment and / or prevention of herpes simplex virus infection. It is also recommended to use a combination of base and immunosuppressant in the manufacture of these compounds.
机译:药物成分包括与单纯疱疹病毒相似的活性核素,例如阿昔洛韦/伐昔洛韦或喷昔洛韦/泛昔洛韦,以及作为同时使用的混合制剂的免疫抑制剂,在治疗和/或预防单纯疱疹中依次分离病毒感染。还建议在这些化合物的生产中结合使用碱和免疫抑制剂。

著录项

  • 公开/公告号AR005551A1

    专利类型

  • 公开/公告日1999-06-23

    原文格式PDF

  • 申请/专利权人 NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD.;

    申请/专利号AR1997P100303

  • 发明设计人

    申请日1997-01-24

  • 分类号A61K31/52;A61K38;A61K31;A61K31/522;A61K31/57;A61K31/573;A61K31/66;A61K31/665;A61K31/675;A61K38/13;A61K45;A61P31;A61P31/22;

  • 国家 AR

  • 入库时间 2022-08-22 02:28:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号